Nerve Disorder Guillain Barre Syndrome Officially Added As Side Effect For AstraZeneca COVID Vaccine

Nerve disorder Guillain Barre Syndrome has been officially added as a side effect for the AstraZeneca COVID vaccine branded as Covishield in India.

The Medicines and Healthcare products Regulatory Agency of UK has added a serious nerve disorder as a possible side effect to the AstraZeneca Covid-19 vaccine after a handful of cases were linked to the jab.

Guillain-Barre syndrome (GBS) itself is a rare nerve disorder that can cause paralysis, but recent data has shown the likelihood ...

Subscribe to view this content.

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].